Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - Europe

Europe

Revenue in the Sleep Aids market amounts to €1.57k in 2024. The market is expected to grow annually by 4.43% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,950 in 2024).
In relation to total population figures, per person revenues of €1.86 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids market in Europe is experiencing significant growth due to changing customer preferences and increasing demand for sleep aids. Customers in Europe are becoming more aware of the importance of a good night's sleep and are actively seeking solutions to improve their sleep quality. This has led to a surge in the demand for sleep aids across the region.

Customer preferences: Customers in Europe are increasingly prioritizing their sleep and are willing to invest in products that can help them achieve a better night's sleep. With hectic lifestyles and high levels of stress, many individuals are struggling with sleep disorders and insomnia. As a result, there is a growing demand for sleep aids such as sleep trackers, sleep masks, herbal supplements, and sleep-promoting technologies.

Trends in the market: One of the key trends in the Sleep Aids market in Europe is the growing popularity of sleep trackers and wearable devices. These devices monitor sleep patterns and provide valuable insights into sleep quality, helping individuals identify and address sleep issues. Sleep trackers are becoming more advanced, offering features such as heart rate monitoring and personalized sleep recommendations. Another trend in the market is the increasing demand for natural and herbal sleep aids. Customers in Europe are becoming more conscious of the potential side effects of pharmaceutical sleep aids and are seeking natural alternatives. Herbal supplements and teas containing ingredients like chamomile, lavender, and valerian root are gaining popularity as they are perceived as safer and more gentle on the body.

Local special circumstances: One of the unique factors influencing the Sleep Aids market in Europe is the cultural emphasis on work-life balance and well-being. Many European countries have a strong focus on quality of life, and sleep is considered an essential component of overall well-being. This cultural mindset is driving the demand for sleep aids as individuals strive to improve their sleep quality and achieve a better work-life balance.

Underlying macroeconomic factors: The Sleep Aids market in Europe is also influenced by underlying macroeconomic factors. The region has a high standard of living and disposable income, allowing individuals to invest in sleep aids and prioritize their sleep. Additionally, the aging population in Europe is more susceptible to sleep disorders and is driving the demand for sleep aids. In conclusion, the Sleep Aids market in Europe is witnessing significant growth due to changing customer preferences and increasing awareness about the importance of sleep. Customers are seeking solutions to improve their sleep quality, leading to a surge in the demand for sleep aids. The market is characterized by the growing popularity of sleep trackers and wearable devices, as well as the increasing demand for natural and herbal sleep aids. The cultural emphasis on work-life balance and well-being in Europe further contributes to the growth of the market. Overall, the Sleep Aids market in Europe is expected to continue expanding as individuals prioritize their sleep and invest in products that can help them achieve a better night's rest.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.